Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based
therapeutics, announced today that management will present a company
overview at the Canaccord 34 th Annual Growth Conference in
Boston, MA on Wednesday, August 13, 2014, at 4:30 pm, ET.
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative
RNA-based therapeutics, announced today that management is scheduled to
present a company overview at the following investor conferences in
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.